Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC MR 409 | 1445155-39-4 | 99.5% | 3395.91 | 1 MG
SDP

Supplier:  Medchemexpress LLC HYP33041MG

Encompass_Preferred

MR 409 is a selected growth hormone-releasing hormone (GHRH) agonist for research use only. It demonstrates neuroprotective effects by enhancing endogenous neurogenesis and inhibits the in vivo growth of lung cancer. This compound can stimulate endogenous neurogenesis and improve tMCAO-induced loss of neuroplasticity.

  • Enhances endogenous neurogenesis in cerebral ischemic mice
  • Inhibits in vivo growth of lung cancer
  • Reduces plasma levels of IL-2, IL-6, IL-10, and TNF-α
  • Suppresses p53 expression in bovine pulmonary arterial endothelial cells
  • Induces activation of JAK2, STAT3, and ERK1/2

Catalog No. 50-003-97302


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.